ADRB3 and hypertensive disorder: Firstly, an important consideration for a β3AR stimulation strategy in patients with peripheral arterial disease is the contraindication in patients with extreme hypertension (systolic blood pressure >180 mm Hg), due to a possible potentiating effect.